Scientists looking at the antiviral mechanisms of two previously identified human monoclonal antibodies have found they potently inhibit chikungunya virus (CHIKV) at multiple stages of infection.

Read the article:
Scientists find effective antiviral mechanisms to inhibit chikungunya virus